MUSTANG BIO, INC. Amortization of Debt Discount (Premium)
MUSTANG BIO, INC. (MBIO) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2025-03-28
- MUSTANG BIO, INC. amortization of debt discount (premium) for the quarter ending 2024-12-31 was $0.00.
- MUSTANG BIO, INC. amortization of debt discount (premium) for the quarter ending 2024-09-30 was $0.00.
- MUSTANG BIO, INC. amortization of debt discount (premium) for the quarter ending 2024-06-30 was $0.00.
- MUSTANG BIO, INC. amortization of debt discount (premium) for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. amortization of debt discount (premium) for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- MUSTANG BIO, INC. amortization of debt discount (premium) for fiscal 2023 was $118.00K, a 74.89% decline from fiscal 2022.
- MUSTANG BIO, INC. amortization of debt discount (premium) for fiscal 2022 was $470.00K.
- MUSTANG BIO, INC. amortization of debt discount (premium) for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 7 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 10 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $0.00 derived: sum of 3 quarters · filed 2025-03-28 | $0.00 10-K · filed 2025-03-28 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 4 quarters · filed 2025-03-28 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-28 | $0.00 derived: sum of 4 quarters · filed 2025-03-28 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $0.00 derived: sum of 3 quarters · filed 2025-03-28 | -$25.00K derived: sum of 4 quarters · filed 2025-03-28 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | -$25.00K derived: sum of 3 quarters · filed 2025-03-28 | $118.00K 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$25.00K derived: sum of 2 quarters · filed 2024-11-08 | $118.00K 10-Q · filed 2024-11-08 | $260.00K derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $118.00K 10-Q · filed 2024-08-13 | $260.00K derived: sum of 3 quarters · filed 2024-08-13 | $403.00K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $143.00K 10-Q · filed 2024-05-15 | $285.00K derived: sum of 2 quarters · filed 2024-05-15 | $428.00K derived: sum of 3 quarters · filed 2024-05-15 | $576.00K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $285.00K derived: sum of 2 quarters · filed 2024-03-11 | $433.00K derived: sum of 3 quarters · filed 2024-03-11 | $470.00K 10-K · filed 2024-03-11 | ||
| 2022-09-30 | $143.00K 10-Q · filed 2023-11-14 | $291.00K derived: sum of 2 quarters · filed 2023-11-14 | $328.00K 10-Q · filed 2023-11-14 | $310.00K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $148.00K 10-Q · filed 2023-08-14 | $185.00K 10-Q · filed 2023-08-14 | $167.00K derived: sum of 3 quarters · filed 2023-08-14 | $167.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $19.00K 10-Q · filed 2023-05-12 | $19.00K derived: sum of 2 quarters · filed 2023-05-12 | $19.00K derived: sum of 3 quarters · filed 2023-05-12 | $19.00K derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $0.00 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2022-08-11 | $1.79M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-05-12 | $1.79M derived: sum of 3 quarters · filed 2022-05-12 | $2.06M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.79M derived: sum of 2 quarters · filed 2022-03-23 | $2.06M derived: sum of 3 quarters · filed 2022-03-23 | $2.32M 10-K · filed 2022-03-23 | ||
| 2020-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.06M derived: sum of 2 quarters · filed 2021-11-12 | $2.32M 10-Q · filed 2021-11-12 | $2.56M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $529.00K 10-Q · filed 2021-08-16 | $773.00K derived: sum of 3 quarters · filed 2021-08-16 | $1.01M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $259.00K 10-Q · filed 2021-05-14 | $503.00K derived: sum of 2 quarters · filed 2021-05-14 | $737.00K derived: sum of 3 quarters · filed 2021-05-14 | $969.00K derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2019-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $478.00K derived: sum of 2 quarters · filed 2021-03-24 | $710.00K derived: sum of 3 quarters · filed 2021-03-24 | $710.00K 10-K · filed 2021-03-24 | ||
| 2019-09-30 | $234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $466.00K derived: sum of 2 quarters · filed 2020-11-06 | $466.00K 10-Q · filed 2020-11-06 | $466.00K derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2019-06-30 | $232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $232.00K 10-Q · filed 2020-08-10 | $232.00K derived: sum of 3 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $0.00 10-K · filed 2018-03-29 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | |||||
| 2016-12-31 | $673.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $763.00K 10-K · filed 2018-03-29 | ||||
| 2016-09-30 | $90.00K 10-Q · filed 2017-11-14 | |||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-29 | |||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |